A Review on Clinical Studies of Acupuncture and Moxibustion Therapy for Acute Herpes Zoster

Article information

Acupunct. 2015;32(3):147-161
1Department of Acupuncture & Moxibustion Medicine, Korean Medicine Hospital of Woosuk University
2Department of Oriental Rehabilitation Medicine, Korean Medicine Hospital of Woosuk University

This study was supported by an academic research grant from Woosuk University in 2015

*Corresponding author : Department of Acupuncture & Moxibustion Medicine, Korean Medicine Hospital of Woosuk University, 46, Eoeun-ro, Wansan-gu, Jeonju-si, Jeollabuk-do, 54987, Republic of Korea, Tel : +82-63-220-8625, E-mail : ju1110@hanmail.net.
Received 2015 August 26; Revised 2015 August 30; Accepted 2015 August 31.

Abstract

Objectives:

The purpose of this study was to review the effectiveness of acupuncture and moxibustion therapy for the treatment of acute herpes zoster.

Methods:

Data was collected by two researchers. Clinical trials on PubMed were retrieved using MeSH terms including “herpes zoster” combined with “acupuncture therapy”, “moxibustion”, “bloodletting”, “electroacupuncture”, and related keywords. We excluded irrelevant studies and included randomized and non-randomized controlled trials, case series and case reports. Finally, we selected a total of thirteen studies and conducted a literature analysis and an object quality assessment.

Results:

Twelve of thirteen studies were about acupuncture and moxibustion combined therapy. Only one study suggested that a single acupuncture therapy is expected to be equally as effective as a common western medicine therapy. There was some evidence related to the effectiveness of moxibustion, venesection and electroacupuncture, but it dealt with combining therapy and was insufficient, and with an inclusion of potential risk factors. Only one study was conducted under approval from an institutional review board. No severe treatment-related adverse events were observed. A quality assessment suggested that there was some weakness in the areas of blinding and concealment.

Conclusions:

There is some evidence that suggests the effectiveness and safety of acupuncture and moxibustion combined therapy as a treatment for acute herpes zoster.

Fig 1

Flow-diagram of trials selection process

Treatment Methods and Points Used in Intervention Group

Summary of Characteristics and Results of Studies

The Conditions of IRB Approval and Obtaining Informed Consents

Assessment of Risk of Bias

References

1. Whitley RJ. Varicella-Zoster Virus Infections. In : Fauci A, Braunwald E, Kasper D, et al, eds. Harrison’s Principles of Internal Medicine 17th edth ed. New York: McGraw-Hill; 2010. p. 1339–41.
2. Schmader KE, Dworkin RH. Herpes Zoster and Postherpetic Neuralgia. In : Benzon H, Raja SN, Fishman SM, Liu S, Cohen SP, eds. Essentials of Pain Medicine 3rd edth ed. Philadelphia: Saunder Elsevier; 2011. p. 358–64.
3. Gross G, Sch fer H, Wassilew S, et al. Herpes Zoster Guideline of the German Dermatology Society(DDG). J Clin Virol 2003;26(3):277–89.
4. Kim SB, Kim JH, Lim KS. A literature study of Herpes Zoster. J Korean Med Opthalmol & Otorhinolaryngol & Dermatol 1994;7(1):85–94.
5. Chun SC, Jee SY, Lee SK. Two Cases of Herpes Zoster and Post-herpetic Neuralgia Improved by Oriental Medicine with Bee Venom Acupuncture. J Korean Med Opthalmol & Otorhinolaryngol & Dermatol 2004;17(2):120–6.
6. Cho YE, Lee SM, Yoon KH, et al. A Case Report of Herpes Zoster Patient Improved by the East-west Medical Combined Treatment. The Acupuncture 2014;31(1):177–86.
7. National Evidence-based Healthcare Collaborating Agency. NECA’s guidance for undertaking systematic reviews and meta-analyses for intervention 1st edth ed. Seoul: National Evidence-based Healthcare Collaborating Agency; 2011. p. 65–91.
8. Zhang H, Xu X, Yang J, Jiang Y. Impacts of electroacupuncture combined with ultraviolet therapy on cytokines of herpes zoster at the acute stage in patients. Zhongguo Zhen Jiu 2015;35(2):145–8.
9. Pan H. Observation of curative effect of herpes zoster treated with acupuncture based on syndrome differentiation combined with pricking and cupping. Zhongguo Zhen Jiu 2011;31(10):901–4.
10. Dai J, Yin AH, Zhou Y, Yin LJ. Herpes zoster treated with meridian-collateral electric information therapy combined with pricking and cupping. Zhongguo Zhen Jiu 2011;31(5):416–9.
11. Tian HY, Hu J, Yang JB. Comparison on therapeutic effect between surround needling plus thin cotton moxibustion and Western medicine for herpes zoster. Zhongguo Zhen Jiu 2011;31(3):219–22.
12. Liu YN, Zhang HX, Huang GF, Zou R, Wei W. Observation on therapeutic effect of electro-acupuncture at Jiaji(EX-B 2) combined with blood-letting and cupping on herpes zoster. Zhongguo Zhen Jiu 2009;29(11):887–90.
13. Li X, Zhang HX, Huang GF, Feng YF, Zou R. Observation on the therapeutic effect of electroacupuncture of Jiaji(EX-B 2) plus regional encircled needling for herpes zoster. Zhen Ci Yan Jiu 2009;34(2):125–7. :135.
14. Huo HM, Yang XP. Observation on therapeutic effect of pricking blood therapy combined with acupuncture on herpes zoster. Zhongguo Zhen Jiu 2007;27(10):729–30.
15. Zhang M, Qiu L, Zhang J. Observation on therapeutic effect of surround needling plus surround moxibustion on herpes zoster. Zhongguo Zhen Jiu 2007;27(2):123–5.
16. Liu ZW, Mo JH, Pang J, Deng X. Thread-moxa in Zhuang folk medicine combined with acupuncture and external application drugs on AIDS patients with herpes zoster: a clinical observation. Zhongguo Zhong Xi Yi Jie He Za Zhi 2013;33(8):1050–3.
17. Ouyang Q, Wei ZJ, Hou YL. Pricking blood therapy combined with ultraviolet irradiation for treatment of acute herpes zoster. Zhongguo Zhen Jiu 2009;29(4):285–8.
18. Yang JX, Xiang KW, Zhang YX. Treatment of herpes zoster with cotton sheet moxibustion: multicentral randomized controlled trial. Zhongguo Zhen Jiu 2012;32(5):417–21.
19. Huang GF, Zhang HX, Xu ZS, Li JW. Comparison of therapeutic effects of different types of acupuncture interventions on herpes zoster in acute stage. Zhen Ci Yan Jiu 2012;37(5):403–8.
20. Ursini T, Tontodonati M, Manzoli L, et al. Acupuncture for the treatment of severe acute pain in herpes zoster: results of a nested, open-label, randomized trial in the VZV Pain Study. BMC Complement Altern Med 2011;11:46.
21. Liu ZS, Peng WN, Liu BY, et al. Clinical practice guideline of acupuncture for herpes zoster. Chin J Integr Med 2013;19(1):58–67.
22. Fleckenstein J, Kramer S, Hoffrogge P, et al. Acupuncture in acute herpes zoster pain therapy (ACUZoster) - design and protocol of a randomised controlled trial. BMC Complement Altern Med 2009;9:31.
23. Peng WN, Liu ZS, Deng YH, Mao M, Yu JN, Du Y. Evaluation of literature quality of acupuncture for treatment of herpes zoster and approach to the laws of treatment. Zhongguo Zhen Jiu 2008;28(2):147–50.
24. Yu XM, Zhu GM, Chen YL, Fang M, Chen YN. Systematic assessment of acupuncture for treatment of herpes zoster in domestic clinical studies. Zhongguo Zhen Jiu 2007;27(7):536–40.
25. Yu F, Xu SW, Zhang W. Clinical observation on treatment of herpes zoster with collateral-pricking and healthy energy strengthening therapy. Zhong Xi Yi Jie He Xue Bao 2005;3(5):400–1.
26. Cao H, Zhu C, Liu J. Wet cupping therapy for treatment of herpes zoster: a systematic review of randomized controlled trials. Altern Ther Health Med 2010;16(6):48–54.
27. Chen B, Gao C, Li C, Chen ZL, Guo Y. Discussion on the suitable diseases and symptoms of bleeding therapy. Zhongguo Zhen Jiu 2009;29(5):397–9.
28. Kim JI, Lee MS, Lee DH, Boddy K, Ernst E. Cupping for treating pain: a systematic review. Evid Based Complement Alternat Med 2011;2011:1–7.
29. Li XW, Yang YK, Xie XM, Bai LN, Zhang XS. Economic evaluation of treating herpes zoster with various methods of acupuncture and moxibustion. J Tradit Chin Med 2012;32(1):125–8.
30. Korean Acupuncture & Moxibustion Medicine Society. Acupuncture and Moxibustion Medicine Gyeonggi: Jipmoondang; 2012. p. 26.
31. Whitley RJ. Human Immunodeficiency Virus Disease : AIDS and Related Disorders. In : Fauci A, Braunwald E, Kasper D, et al, eds. Harrison’s Principles of Internal Medicine 17th edth ed. New York: McGraw-Hill; 2010. p. 1382–459.
32. Sim WS, Choi JH, Han KR, Kim YC. Treatment of Herpes Zoster and Postherpetic Neuralgia. Korean J Pain 2008;21(2):93–6.
33. Johnson RW, Dworkin RH. Treatment of herpes zoster and postherpetic neuralgia. BMJ 2003;326(7392):748.
34. Chen N, Li Q, Yang J, Zhou M, Zhou D, He L. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2014;6(2):CD006866.
35. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007;(44 Suppl)1:S1–26.

Article information Continued

Fig 1

Flow-diagram of trials selection process

Table 1

Treatment Methods and Points Used in Intervention Group

Treatment Ref No Zhang8) Pan9) Dai10) Tian11) Liu12) Li13) Huo14) Zhang15) Liu16) Ouyang17) Yang18) Huang19) Ursini20) Total
Body acupuncture Ashi-points 7
EX-B2 2
EX-HN5 1
BL2 1
CV4 1
CV12 1
GB20 1
GB34 2
KI3 1
LI4 2
LI11 4
LR2 1
LR3 4
PC6 1
SP6 2
SP7 1
SP9 1
SP10 1
ST36 4
ST44 1
TE5 2
TE6 2
Electroacupuncture Ashi-points 1
EX-B2 4
TE6 2
SI3 2
Moxibustion Ashi-points 5
ST36 1
CV4 1
Bloodletting Ashi-points 7
Fire needling Ashi-points 1
Ultra-violet Ashi-points 2

Table 2

Summary of Characteristics and Results of Studies

First author Total N(I, C), age(I, C)
days of illness(I, C)
days of Treatment dropouts
Intervention group Control group Outcome assessment Results Authors’s Conclusion
Zhang8) 34(17, 17)
mean(49, 50)
mean(3.3, 3.1)
10 days
0
W/M+EA+UV W/M (Acy Vit B12)
+TDP
BRT, IT, VAS, LAB(IL-2, IL-6, IL-10) BRT, IT : I earlier than C(p<0.05)
VAS reducing amplitude : I larger than C(p<0.01)
TER : I higher than C(p<0.05), Reduction of IL-6&10 : I>C(p<0.05)
I>C
Intervention more significantly relief pain, shorten the duration of sickness, improve the body immunity, reduce nerve injury.
Pan9) 86(43, 43)
mean(50.1, 49.3)
mean(13.6, 14.1)
7+7 days
0
AC(acupoints selection based on syndrome differentiation) + VTx VTx only Symptoms score*, TER, PHN incidence TER : I higher than C(p<0.01)
TER of damp retention and spleen deficiency
: I higher than C(p<0.05), TER of qi deficiency and blood stasis
: I higher than C(p<0.05)
PHN incidence : I lower than C(p<0.05)
I>C
Intervention is high pertinent and effective, PHN can be reduced significantly and the curative effect is superior to that of control.
Dai10) 200(100, 100)
mean(52.29, 51.71)
mean(4.63, 3.69)
7 days
0
MCEI diagnosis and treatment + VTx W/M (Acy) MER, BRT, IT, PRT, PHN incidence(after 1month) MER : I higher than C(p<0.0001)
PRT, BRT, IT in I obviously shorter than C(p<0.0001)
PHN incidence : I 0 % C 26 %
I>C
Intervention can effectively relieve pain and prevent from PHN promptly.
Tian11) 80(42, 38)
mean(49.0, 48.5)
mean(7.4, 7.0)
10 days
0
sAC + MTx W/M (Acy) MER, SOP, color, quantity, erosion and exudation changes MER : I superior to C(p<0.05)
All the symptom scores : I better than C(all p<0.05)
I>C
The therapeutic effect of Intervention is superior to that of routine W/M.
Liu12) 53(31, 22)
mean(48.65, 47.91)
mean(5.14, 4.76)
10 days
0
EA + VTx W/M (Val, indomethacin, Vit B1, B12) TER, score of pain relief, pruritus, burning, sleep TER : I better than C(p<0.05)
All the symptom scores : I superior to C(all p<0.01)
I>C
Intervention is a better therapy and its effect is better than that of routine W/M therapy
Li13) 80(40, 40)
mean(46.36, 44.79)
unknown
10 days
0
EA + sAC W/M (Val, Vit B1, B12) TER, VAS, Time (scabbing area was equal or over 50 %), TER : I superior to C(p<0.01), VAS reduction : I better than C(p<0.01) I>C
Intervention is effective in facilitating the crust formation and pain relief, better than medication.
Huo14) 240(120, 120)
mean(48.45, 47.32)
mean(3.05, 2.95)
10 days
0
AC+VTx W/M (Acy) TER, PRT, BRT, IT TER : I>C difference(p<0.01), All the time : I shorter than C(All p<0.01) I≥C Intervention is an effective therapy for herpes zoster
Zhang15) 72(38, 34)
mean(54.55, 54.95)
mean(2.81, 5.09)
10 days
0
sAC+sMTx sAC TER(within 3 days), PRT, BRT, IT TER : I better than C(p<0.05)
Time : I shorter than C
(PRT : p=0.0042<0.01, BRT : p<0.05, IT : p<0.05)
PHN incidence cases : I 0, C 3
I>C Intervention has obvious therapeutic effect on herpes zoster
Liu16) AIDS patients
60(30, 30)
mean(44, 46)
I+C mean(3.0±1.5)
7+7 days
0
Thread MTx+sAC +Ointment W/M (Famci, Nimesulide, Vit B1, ribavirin) TER, MER, VAS, QS, BRT, IT, SRT, PHN incednce(after 1year) TER : I better than C(p>0.05)
MER : I better than C(p<0.01)
VAS(p<0.05), QS(p<0.01), BRT(p<0.05), IT(p<0.05), SRT(p<0.05), 1yr PHN incidence rate(p<0.01) : I lower than C
I≥C
Intervention is effective therapy. It relieved pain quickly, shortened course of disease, and improved quality of sleep.
Ouyang17) 130(65, 65)
mean(54.1 55.4)
mean(4.1 3.7)
7 days
0
VTx + UV W/M (Acy and other) Cured rate, TER, PHN incidence, Symptom scores(pain, rash and sleep) BRT, IT, SRT, PRT Cured rate(p<0.01), TER(p<0.01) : I higher than C
PHN incidence : I lower than C(p<0.05), Pain(p<0.01), Sleep(p<0.05), Affected skin(p<0.05) reduction : I larger than C BRT(p<0.05), IT(p<0.05), SRT(p<0.05), PRT(p<0.01) : I shorter than C
I≥C
Intervention has rapid therapeutic effect, effectively shortens duration of illness, decreases the incidence rate of HPN. And it is a safe remedy.
Yang18) 120(60, 60)
mean(47.1±10.7, 46.3±10.7)
mean(5.1±4.8, 5.2±4.9)
7 days
0
VTx+MTx + Plaster W/M (Val, Vit B1) MER, TER, PRI, PPI, VAS, symptom score, BRT, IT, SRT, PRT, recurrence rate(after 1 month) MER(p<0.01), TER(p<0.05) : I higher than C Reduction of PPI, PRI, VAS(all p<0.01) : I larger than C
Reduction of symptom scores(all p<0.05) : I larger than C
BRT(p<0.05), IT(p<0.05), SRT(p<0.05), PRT(p<0.01) : I shorter than C
Recurrence rate : I lower than C(p<0.01)
I>C
Intervention is quick effect and short-time treatment for HZ. It is safe and effective therapy.
Huang19) 183(36,35,43,39,36)
mean(44.1, 46.7, 44.9, 47.3, 46.0)
mean(3.6, 3.1, 3.8, 3.9, 3.3)
10 days
6
(A : sAC B : MTx C : fire needle D : VTx) +EA, sAC E : W/M (Val, Vit B1) BRT, IT, DcT, TER, VAS, BRT, IT, DcT, TER among the 5 groups : no significant differences(p>0.05).
VAS : A·B·C·D significantly lower from the 7th day than E(p<0.05).
I≥C
Intervention of A,B,C,D are effective, being comparable to the E in the curative effect and improvement of blisters, and better than E in pain relief.
Ursini20) 102(52, 50)
mean(67.1±12.8 65.5±12.8)
Unknown
28 days
36(rapid recovery 28)
AC(twice weekly) W/M(pregabali n, local anaesthesia, peridural neural blockade, opioid) Response rates, VAS, MPQ, mean changes in pain, differences in PHN incidence(after 3 month). Both(I,C) were largely effective.
Response rates(p=0.8>0.05) mean reduction of VAS p=0.12>0.05), MPG(p=0.9>0.05), PHN Incidence(p=0.5>0.05) mean Area-under-the-curve(AUC) during follow-up(p=0.4>0.05),: no significant differences,
I=C
This controlled and randomized trial provides the first evidence of a potential role of AC for the treatment of acute herpetic pain.
*

The results of symptoms were not reported in the study.(Pan 2011)

W/M : western medicine. AC : acupuncture. sAC : surrounding acupuncture or encircled-acupuncture. MTx : moxibustion. VTx : venesection. EA : electroacupuncture.

MCEI : meridian-collateral electric information. Acy : acyclovir. Val : valaciclovir, Famci : famciclovir. BRT : blister relief time. IT : incrustation time. PRT : pain relief time. SRT : skin repair time.

DcT : decrustation time, TER : total effective rate(the cured and markedly cured rate). MER : markedly effective rate. PHN : post-herpetic neuralgia. VAS : visual analogue scale. SOP : score of pain.

QS : sleep quality score. PRI : pain rating index. PPI : present pain intensity, MPG : McGill pain qustionnaire. IRB : institutional review board. Co : consents. AE : adverse event.

Table 3

The Conditions of IRB Approval and Obtaining Informed Consents

First author year IRB approval Informed consents Adverse events
Zhang8) × ×
Pan9) × Mild(I1 C1)
Dai10) × × ×
Tian11) × ×
Liu12) × ×
Li3) × ×
Huo14) × × Mild(C2)
Zhang15) × × ×
Liu16) × ×
Ouyang17) × Mild(I1 C4)
Yang18) × Mild(C6)
Huang19) × ×
Ursini20) ×
Total 1(7.7 %) 10(76.9 %) 4(30.7 %)
*

I : intervention group. C : control group.

Table 4

Assessment of Risk of Bias

First author year 1 2 3 4 5 6 7
Zhang8) L U U L L L U
Pan9) L U U L L H U
Dai10) L U U L L L U
Tian11) L U U L U L U
Liu12) L U U L L L U
Li13) L U U L L L U
Huo14) U U U L L L U
Zhang15) L U U L L L L
Liu16) L U U L L L U
Ouyang17) L U U L L L L
Yang18) L L U L U L L
Huang19) L L U L H L U
Ursini20) L L U L L L U